Literature DB >> 22200959

Anthelmintic activity of medicinal plants used in Côte d'Ivoire for treating parasitic diseases.

Witabouna Mamidou Koné1, Mireille Vargas, Jennifer Keiser.   

Abstract

Natural products play an important role in the discovery and development of new pharmaceuticals. In the present study, we assessed the anthelmintic properties of medicinal plants used in Cote d'Ivoire. Ethanolic extracts from 50 medicinal plants were tested in vitro against trematodes (Echinostoma caproni, Schistosoma mansoni) and nematodes (Ancylostoma ceylanicum, Heligmosomoides bakeri, Trichuris muris). Active extracts were evaluated for their cytotoxicity and followed up in vivo in mice harbouring adult S. mansoni, E. caproni and T. muris at single oral doses of 400 or 800 mg/kg. All extracts tested were active against at least one helminths species. Ten of the 65 extracts tested (15.4%) in vitro revealed activity against all helminths tested. Of 65 extracts tested in vitro at a concentration of 2 mg/ml, all caused death of schistosomula and 34.4% and 39.1% were lethal against adult S. mansoni and E. caproni 72 h post-incubation, respectively. The highest activity against A. ceylanicum in vitro was observed with Sclerocarya birrea at 2 mg/ml, which resulted in death of adult worms and inhibition of activity of third-stage larvae (L3). Of the extracts, 41.5% completely inhibited movement of H. bakeri L3 at minimal lethal concentration (MLC) values of 20-200 μg/ml 48 h post-incubation, and 15.4% paralysed adult H. bakeri at 200 μg/ml 72 h after incubation. Of the extracts, 19% resulted in death of adult T. muris at MLC values of 10-100 μg/ml. In vivo, none of the extracts tested revealed activity against E. caproni. Olax subscorpioidea achieved total and female worm burden reductions of 60% and 84%, respectively in S. mansoni-infected mice. Combretum mucronatum was the most active extracts in vivo against T. muris with a worm burden reduction of 85.3%. In conclusion, several of the medicinal plants used in Côte d'Ivoire are active against different helminths, hence might play a role in the treatment of helminthiases. Further studies are necessary to isolate the active components from these extracts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200959     DOI: 10.1007/s00436-011-2771-z

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  44 in total

1.  Antibacterial, anthelmintic and anti-amoebic activity in South African medicinal plants.

Authors:  L J McGaw; A K Jäger; J van Staden
Journal:  J Ethnopharmacol       Date:  2000-09       Impact factor: 4.360

2.  Antiparasitic activities of medicinal plants used in Ivory Coast.

Authors:  T Okpekon; S Yolou; C Gleye; F Roblot; P Loiseau; C Bories; P Grellier; F Frappier; A Laurens; R Hocquemiller
Journal:  J Ethnopharmacol       Date:  2004-01       Impact factor: 4.360

3.  Prevalence of anthelmintic resistance in gastrointestinal nematodes of dairy goats under extensive management conditions in southwestern France.

Authors:  C Chartier; F Soubirac; I Pors; A Silvestre; J Hubert; C Couquet; J Cabaret
Journal:  J Helminthol       Date:  2001-12       Impact factor: 2.170

Review 4.  From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis.

Authors:  Jürg Utzinger; Eliézer K N'goran; Conor R Caffrey; Jennifer Keiser
Journal:  Acta Trop       Date:  2010-09-08       Impact factor: 3.112

5.  The composition, geographical variation and antimicrobial activity of Lippia javanica (Verbenaceae) leaf essential oils.

Authors:  A M Viljoen; S Subramoney; S F van Vuuren; K H C Başer; B Demirci
Journal:  J Ethnopharmacol       Date:  2005-01-04       Impact factor: 4.360

6.  The use of microfluorometric method for activity-guided isolation of antiplasmodial compound from plant extracts.

Authors:  M N Shuaibu; P A Wuyep; T Yanagi; K Hirayama; T Tanaka; I Kouno
Journal:  Parasitol Res       Date:  2008-01-24       Impact factor: 2.289

7.  Antischistosomal bioactivity of isoflavonoids from Millettia thonningii (Leguminosae).

Authors:  J R A Lyddiard; P J Whitfield; A Bartlett
Journal:  J Parasitol       Date:  2002-02       Impact factor: 1.276

Review 8.  Emerging food-borne parasites.

Authors:  P Dorny; N Praet; N Deckers; S Gabriel
Journal:  Vet Parasitol       Date:  2009-06-06       Impact factor: 2.738

9.  In vitro and in vivo efficacy of Monepantel (AAD 1566) against laboratory models of human intestinal nematode infections.

Authors:  Lucienne Tritten; Angelika Silbereisen; Jennifer Keiser
Journal:  PLoS Negl Trop Dis       Date:  2011-12-27

10.  Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden.

Authors:  Peter J Hotez; Aruna Kamath
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25
View more
  16 in total

1.  In vivo anthelmintic activity of Anogeissus leiocarpus Guill & Perr (Combretaceae) against nematodes in naturally infected sheep.

Authors:  Dramane Soro; Witabouna Mamidou Koné; Bassirou Bonfoh; Bernadin Dro; Kassédo Bénédicte Toily; Kagoyire Kamanzi
Journal:  Parasitol Res       Date:  2013-05-09       Impact factor: 2.289

2.  Biochemical and ultrastructural changes in Raillietina echinobothrida in vitro exposed to extract of Lysimachia ramosa.

Authors:  Paulomi Dey; Bishnupada Roy
Journal:  J Parasit Dis       Date:  2018-03-13

3.  Phenolic Metabolites of Dalea ornata Affect Both Survival and Motility of the Human Pathogenic Hookworm Ancylostoma ceylanicum.

Authors:  Kaitlin Deardorff; William Ray; Eric Winterstein; MacKenzie Brown; Jocelyn McCornack; Brianda Cardenas-Garcia; Kiah Jones; Sarah McNutt; Shannon Fulkerson; Daneel Ferreira; Charlotte Gény; Xiaoyan Chen; Gil Belofsky; Blaise Dondji
Journal:  J Nat Prod       Date:  2016-09-01       Impact factor: 4.050

4.  In vitro anthelmintic assessment of selected phytochemicals against Hymenolepis diminuta, a zoonotic tapeworm.

Authors:  Arun K Yadav
Journal:  J Parasit Dis       Date:  2014-09-11

5.  In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility.

Authors:  Rebecca S Treger; Joseph Otchere; Martin F Keil; Josephine E Quagraine; Ganesha Rai; Bryan T Mott; Debbie L Humphries; Michael Wilson; Michael Cappello; Jon J Vermeire
Journal:  Am J Trop Med Hyg       Date:  2013-12-02       Impact factor: 2.345

6.  Sensitivity of two in vitro assays for evaluating plant activity against the infective stage of Haemonchus contortus strains.

Authors:  A Al-Rofaai; W A Rahman; Mahfoudh Abdulghani
Journal:  Parasitol Res       Date:  2012-09-08       Impact factor: 2.289

7.  Inhibitory effect of Ferula asafoetida L. (Umbelliferae) on Blastocystis sp. subtype 3 growth in vitro.

Authors:  Hala K El Deeb; Faisal M Al Khadrawy; Ayman K Abd El-Hameid
Journal:  Parasitol Res       Date:  2012-05-15       Impact factor: 2.289

8.  Anthelmintic activity of carvacryl acetate against Schistosoma mansoni.

Authors:  Josué de Moraes; Aline A Leite Carvalho; Eliana Nakano; Antonia Amanda Cardoso de Almeida; Thiago Henrique da Costa Marques; Luciana Nalone Andrade; Rivelilson Mendes de Freitas; Damião Pergentino de Sousa
Journal:  Parasitol Res       Date:  2012-10-21       Impact factor: 2.289

9.  A penta-substituted pyridine alkaloid from the rhizome of Jatropha elliptica (Pohl) Muell. Arg. is active against Schistosoma mansoni and Biomphalaria glabrata.

Authors:  Aldenir Feitosa dos Santos; Saskya Araújo Fonseca; Fernanda Andrade César; Mônica Camelo Pessoa de Azevedo Albuquerque; José Valfrido Santana; Antônio Euzébio Goulart Santana
Journal:  Parasitol Res       Date:  2014-02-06       Impact factor: 2.289

10.  Pharmacological screening of Monotheca buxifolia (Falc.) A. DC. for antinociceptive, anti-inflammatory and antipyretic activities.

Authors:  Irfan Ullah; Jamshaid Ali Khan; Muhammad Shahid; Ajmal Khan; Achyut Adhikari; Peer Abdul Hannan; Ibrahim Javed; Faisal Shakeel; Umar Farooq
Journal:  BMC Complement Altern Med       Date:  2016-08-05       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.